ro13-9904 and Chronic-Pain

ro13-9904 has been researched along with Chronic-Pain* in 2 studies

Other Studies

2 other study(ies) available for ro13-9904 and Chronic-Pain

Article	Year
Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease. Haematologica, 2023, 02-01, Volume: 108, Issue:2 Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Chronic Pain; Humans	2023
Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 The early shortage of novel coronavirus disease (COVID-19) tests in the United States led many hospitals to first screen for common respiratory pathogens, and only if this screen was negative to proceed with COVID-19 testing. We report a case of a 56-year-old woman with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) coinfection with group A Topics: Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Ceftriaxone; Chicago; Chronic Pain; Coinfection; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Female; Humans; Hydroxychloroquine; Hypertension; Lung; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Streptococcal Infections; Streptococcus pyogenes; Tomography, X-Ray Computed; Treatment Outcome	2020

Article

Year

Therapeutic potential of β-lactam ceftriaxone for chronic pain in sickle cell disease.

Haematologica, 2023, 02-01, Volume: 108, Issue:2

Topics: Anemia, Sickle Cell; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Chronic Pain; Humans

2023

Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic.

The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6

The early shortage of novel coronavirus disease (COVID-19) tests in the United States led many hospitals to first screen for common respiratory pathogens, and only if this screen was negative to proceed with COVID-19 testing. We report a case of a 56-year-old woman with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) coinfection with group A

Topics: Antibodies, Monoclonal, Humanized; Azithromycin; Betacoronavirus; Ceftriaxone; Chicago; Chronic Pain; Coinfection; Coronavirus Infections; COVID-19; Extracorporeal Membrane Oxygenation; Female; Humans; Hydroxychloroquine; Hypertension; Lung; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Streptococcal Infections; Streptococcus pyogenes; Tomography, X-Ray Computed; Treatment Outcome

2020